{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 17169, "pageSize": 18, "pageCount": 17777, "rows": [ { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/2", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "efccf951-8a44-4762-b8dd-dffbd7e71970", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a company overview and recent financial performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 3, "slideType": "table_of_contents", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/3", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "efccf951-8a44-4762-b8dd-dffbd7e71970", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a company overview and recent financial performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 4, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/4", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "efccf951-8a44-4762-b8dd-dffbd7e71970", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a company overview and recent financial performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 5, "slideType": "executive_summary", "function": "establish_context", "notes": "Includes a financial snapshot with valuation multiples and a product-level sales table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/5", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "efccf951-8a44-4762-b8dd-dffbd7e71970", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a company overview and recent financial performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 6, "slideType": "other", "function": "analyze_data", "notes": "The chart uses a dual-axis approach to show price (line) and volume (bars) with annotated callouts for specific events.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/6", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "bf50e422-96a9-446c-90f1-ef787140617a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document provides context for Taro's financial performance", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 7, "slideType": "other", "function": "analyze_data", "notes": "The slide highlights the lack of analyst coverage and low float (34%) resulting in low trading volume for Taro Pharma.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/7", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "bf50e422-96a9-446c-90f1-ef787140617a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document provides context for Taro's financial performance", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 8, "slideType": "executive_summary", "function": "analyze_data", "notes": "The slide uses a mix of historical (A) and estimated (E) data, with specific H1 comparisons.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/8", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "bf50e422-96a9-446c-90f1-ef787140617a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document provides context for Taro's financial performance", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 9, "slideType": "other", "function": "analyze_data", "notes": "The slide uses a combination of annual historical/forecast data and half-year comparisons to explain cost structure changes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/9", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 10, "slideType": "executive_summary", "function": "analyze_data", "notes": "Includes a detailed income statement table with Q1, Q2, H1 2012 actuals and 2012 estimates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/10", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 11, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/11", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 12, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "Includes two bar charts showing historical/projected growth and a median benchmark line.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/12", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-12", "loopMatches": [ { "to": 14, "from": 12, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "f7b706e2-cbe9-4c86-a2b1-72d90dd7a7df", "evidence": "The document presents multiple peer benchmarking analyses", "position": 0, "objective": "Identify patterns in peer benchmarking", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 13, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "Taro is highlighted in blue in each chart, while peers are in grey. Medians are indicated by red dashed lines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/13", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-13", "loopMatches": [ { "to": 14, "from": 12, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "f7b706e2-cbe9-4c86-a2b1-72d90dd7a7df", "evidence": "The document presents multiple peer benchmarking analyses", "position": 0, "objective": "Identify patterns in peer benchmarking", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 14, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "Includes specific footnotes regarding adjustments for peer data (e.g., Actavis, Paddock, Flomax).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/14", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-14", "loopMatches": [ { "to": 14, "from": 12, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "f7b706e2-cbe9-4c86-a2b1-72d90dd7a7df", "evidence": "The document presents multiple peer benchmarking analyses", "position": 0, "objective": "Identify patterns in peer benchmarking", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 15, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/15", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-15", "loopMatches": [ { "to": 20, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "69a62026-f22f-4cb8-8315-67f1e16e19c1", "evidence": "The document presents various valuation metrics and analyses", "position": 1, "objective": "Understand the valuation of Taro", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "39dffcbe-e19a-4cdd-9f0a-ea53bf4e24c8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Valuation", "beatSlug": null, "evidence": "The document presents various valuation metrics and analyses", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 16, "slideType": "comparison_table", "function": "compare_peers", "notes": "Includes specific financial benchmarks like P/E ratios and valuation ranges relative to Sun Pharma's offer price.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/16", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-16", "loopMatches": [ { "to": 20, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "69a62026-f22f-4cb8-8315-67f1e16e19c1", "evidence": "The document presents various valuation metrics and analyses", "position": 1, "objective": "Understand the valuation of Taro", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "39dffcbe-e19a-4cdd-9f0a-ea53bf4e24c8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Valuation", "beatSlug": null, "evidence": "The document presents various valuation metrics and analyses", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 17, "slideType": "comparison_table", "function": "cite_precedent", "notes": "Includes data on price bumps, offer premiums, and transaction duration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/17", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-17", "loopMatches": [ { "to": 20, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "69a62026-f22f-4cb8-8315-67f1e16e19c1", "evidence": "The document presents various valuation metrics and analyses", "position": 1, "objective": "Understand the valuation of Taro", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "39dffcbe-e19a-4cdd-9f0a-ea53bf4e24c8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Valuation", "beatSlug": null, "evidence": "The document presents various valuation metrics and analyses", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes sensitivity tables for WACC vs Terminal EBITDA Multiple, WACC vs Implied Perpetuity Growth Rate, and WACC vs Terminal Value as a % of Enterprise Value.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/18", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-18", "loopMatches": [ { "to": 20, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "69a62026-f22f-4cb8-8315-67f1e16e19c1", "evidence": "The document presents various valuation metrics and analyses", "position": 1, "objective": "Understand the valuation of Taro", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "39dffcbe-e19a-4cdd-9f0a-ea53bf4e24c8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Valuation", "beatSlug": null, "evidence": "The document presents various valuation metrics and analyses", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart highlights a period of multiple uplift attributed to stock price appreciation ahead of product pricing increases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/19", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-19", "loopMatches": [ { "to": 20, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "69a62026-f22f-4cb8-8315-67f1e16e19c1", "evidence": "The document presents various valuation metrics and analyses", "position": 1, "objective": "Understand the valuation of Taro", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "39dffcbe-e19a-4cdd-9f0a-ea53bf4e24c8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Valuation", "beatSlug": null, "evidence": "The document presents various valuation metrics and analyses", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }